The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Brain Research Bulletin

• Publication date

  2005-12-15

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1016/J.BRAINRESBULL.2005.08.009PMID 16325001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deficits in a lateralized associative learning task in dopamine‐depleted rats with functional recovery by dopamine‐rich transplants

  2004cited by this paper
• Paw preference, rotation, and dopamine function in Collins HI and LO mouse strains.

  1997cited by this paper
• Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae.

  1996cited by this paper
• The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments.

  1996cited by this paper
• Experimental models and behavioural tests used in the study of Parkinson's disease.

  1995cited by this paper
• Functional neural transplantation

  1994cited by this paper
• Analysis of two measures of paw preference in a large population of inbred mice.

  1994cited by this paper
• A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology.

  1994cited by this paper
• A novel population of tyrosine hydroxylase immunoreactive neurones in the basal forebrain of the common marmoset (Callithrix jacchus).

  1993cited by this paper
• Lateralization and reaching skill related: results and implications from a large sample of Long-Evans rats.

  1992cited by this paper
• The Importance of Graft Placement and Task Complexity for Transplant‐Induced Recovery of Simple and Complex Sensorimotor Deficits in Dopamine Denervated Rats

  1990cited by this paper
• Deficits in response space following unilateral striatal dopamine depletion in the rat

  1989cited by this paper
• Effects of unilateral dorsal and ventral striatal dopamine depletion on visual neglect in the rat: a neural and behavioural analysis.

  1989cited by this paper
• Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions.

  1987cited by this paper
• Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention

  1985cited by this paper
• Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites.

  1983cited by this paper
• Grafts of embryonic substantia nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway.

  1981cited by this paper
• Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity.

  1976cited by this paper
• Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function

  1976cited by this paper
• Neurochemical Correlate of a Spatial Preference in Rats

  1974cited by this paper
• Nigrostriatal bundle damage and the lateral hypothalamic syndrome.

  1974cited by this paper
• Further analysis of sensory inattention following lateral hypothalamic damage in rats.

  1974cited by this paper
• Sensorimotor syndrome produced by lesions of the amygdala and lateral hypothalamus.

  1973cited by this paper
• Sensory Neglect Produced by Lateral Hypothalamic Damage

  1971cited by this paper

• PDGFRα inhibition reduces myofibroblast expansion in the fibrotic rim and enhances recovery after ischemic stroke

  2025cites this paper
• The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity

  2025cites this paper
• Electroconvulsive Therapy Induces Dopaminergic Axon Regeneration, Corticostriatal Remodeling, and Restoration of Motor Function in Parkinsonian Mice

  2025cites this paper
• Intra‐striatal infusion of the small molecule alpha‐synuclein aggregator, FN075, does not enhance parkinsonism in a subclinical AAV‐alpha‐synuclein rat model

  2024cites this paper
• Exploring the Central Mechanisms of Botulinum Toxin in Parkinson’s Disease: A Systematic Review from Animal Models to Human Evidence

  2023cites this paper
• Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicity

  2023cites this paper
• Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioural tests.

  2022cites this paper
• Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin

  2022cites this paper
• Better Outcomes with Intranigral versus Intrastriatal Cell Transplantation: Relevance for Parkinson’s Disease

  2022cites this paper
• Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats

  2022cites this paper
• Investigating cell therapies in animal models of Parkinson's and Huntington's disease: Current challenges and considerations.

  2022cites this paper
• Lateralization in Hemiparkinsonian Rats Is Affected by either Deep Brain Stimulation or Glutamatergic Neurotransmission in the Inferior Colliculus

  2022cites this paper
• Subthalamic nucleus deep brain stimulation induces sustained neurorestoration in the mesolimbic dopaminergic system in a Parkinson's disease model.

  2021cites this paper
• The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models

  2021cites this paper
• Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents

  2021cites this paper
• Reduced myofibroblast transdifferentiation and fibrotic scarring in ischemic stroke after imatinib treatment

  2021cites this paper
• A sequential methodology for integral evaluation of motor and non-motor behaviors in parkinsonian rodents

  2020cites this paper
• PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats.

  2020cites this paper
• The Amphetamine Induced Rotation Test: A Re-Assessment of Its Use as a Tool to Monitor Motor Impairment and Functional Recovery in Rodent Models of Parkinson’s Disease

  2019cites this paper
• Human Autologous iPSC-Derived Dopaminergic Progenitors Restore Motor Function in Parkinson's Disease Models.

  2019cites this paper
• Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson’s disease

  2019cites this paper
• Botulinum Neurotoxin-A Injected Intrastriatally into Hemiparkinsonian Rats Improves the Initiation Time for Left and Right Forelimbs in Both Forehand and Backhand Directions

  2019cites this paper
• Optimisation of transplantation methodology in mouse models of Huntington's Disease

  2018cites this paper
• Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.

  2018cites this paper
• Repeated Intrastriatal Botulinum Neurotoxin-A Injection in Hemiparkinsonian Rats Increased the Beneficial Effect on Rotational Behavior

  2018cites this paper
• Unilateral Botulinum Neurotoxin-A Injection into the Striatum of C57BL/6 Mice Leads to a Different Motor Behavior Compared with Rats

  2018cites this paper
• Deep Brain Stimulation in Parkinson's Disease

  2018cites this paper
• The possible role of cerium oxide (CeO2) nanoparticles in prevention of neurobehavioral and neurochemical changes in 6-hydroxydopamine-induced parkinsonian disease

  2017cites this paper
• Choroid plexus-cerebrospinal fluid route for monocyte-derived macrophages after stroke

  2017cites this paper
• Inflammation and Stem Cell Therapy for Stroke

  2017cites this paper
• Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson’s Disease Differently Affects Behavior

  2017cites this paper
• Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals

  2017cites this paper
• Interaction between subclinical doses of the Parkinson’s disease associated gene, &agr;‐synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats

  2017cites this paper
• Animal behavioral assessments in current research of Parkinson's disease.

  2016cites this paper
• Systematic and detailed analysis of behavioural tests in the rat middle cerebral artery occlusion model of stroke: Tests for long-term assessment

  2016cites this paper
• The cannabinoid type-2 (CB2) receptor as a target for anti-inflammatory disease modification in Parkinson's disease

  2016cites this paper
• Monocyte-Derived Macrophages Contribute to Spontaneous Long-Term Functional Recovery after Stroke in Mice

  2016cites this paper
• Human behavioral assessments in current research of Parkinson's disease.

  2016cites this paper
• Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease.

  2016cites this paper
• DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor

  2016cites this paper
• Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.

  2015cites this paper
• Optogenetics enables functional analysis of human embryonic stem cell–derived grafts in a Parkinson's disease model

  2015cites this paper
• Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease

  2015cites this paper
• A partial lesion model of Parkinson's disease in mice--characterization of a 6-OHDA-induced medial forebrain bundle lesion.

  2015cites this paper
• Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease.

  2015cites this paper
• Gene therapy using synthetic microRNA directed against GAD67 has beneficial effect on motor behaviour in 6-OHDA lesioned rats

  2014influential citation
• Changes in components of the brain extracellular matrix after experimental ischemic stroke

  2014influential citation
• Parkinson pathology propagation and long-distance transport in neurons

  2014cites this paper
• Preclinical Models of Levodopa-Induced Dyskinesia

  2014cites this paper
• Overview of Mouse Models of Parkinson's Disease

  2014cites this paper
• Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

  2014influential citation
• The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.

  2013cites this paper
• Cognitive deficits in animal models of basal ganglia disorders.

  2013cites this paper
• Dopamine-rich grafts alleviate deficits in contralateral response space induced by extensive dopamine depletion in rats.

  2013cites this paper
• Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease

  2013cites this paper
• Behavioural recovery on simple and complex tasks by means of cell replacement therapy in unilateral 6‐hydroxydopamine‐lesioned mice

  2013cites this paper
• Glycine Transporter-1 Inhibition Promotes Striatal Axon Sprouting via NMDA Receptors in Dopamine Neurons

  2013cites this paper
• Dopamine Modulates Corticostriatal Inputs During Motor Command Signalilng

  2013cites this paper
• Further characterisation of the LPS model of Parkinson's disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat.

  2013cites this paper
• Human‐Induced Pluripotent Stem Cells form Functional Neurons and Improve Recovery After Grafting in Stroke‐Damaged Brain

  2012cites this paper
• The search for genetic mouse models of prodromal Parkinson's disease.

  2012cites this paper
• Transplanting Intact Donor Tissue Enhances Dopamine Cell Survival and the Predictability of Motor Improvements in a Rat Model of Parkinson’s Disease

  2012cites this paper
• Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites.

  2012cites this paper
• Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.

  2012cites this paper
• Unilateral nigrostriatal 6-hydroxydopamine lesions in mice II: predicting l-DOPA-induced dyskinesia.

  2012cites this paper
• Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.

  2012cites this paper
• Behavioral and histological analysis of a partial double‐lesion model of parkinson‐variant multiple system atrophy

  2012cites this paper
• Closing the gap between clinic and cage: sensori-motor and cognitive behavioural testing regimens in neurotoxin-induced animal models of Parkinson's disease.

  2012cites this paper
• Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease.

  2012cites this paper
• Nigral grafts in animal models of Parkinson's disease. Is recovery beyond motor function possible?

  2012cites this paper
• Neurotoxin-based models of Parkinson's disease.

  2012cites this paper
• Unilateral 6-OHDA Lesions Induce Lateralised Deficits in a ‘Skinner box’ Operant Choice Reaction Time Task in Rats

  2012cites this paper
• Do α-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?

  2012cites this paper
• Behavioural analysis of 6-hydroxydopamine rodent models of Parkinson's disease

  2012influential citation
• Functional Assessment of Subcortical Ischemia

  2011cites this paper
• Integration and function of new neurons generated from fibroblasts and adult neural stem cells in the pathological brain

  2011cites this paper
• Induced Animal Models of Parkinson’s Disease

  2011cites this paper
• Anodal transcranial direct current stimulation relieves the unilateral bias of a rat model of Parkinson's disease

  2011cites this paper
• 6-OHDA Toxin Model in Mouse

  2011cites this paper
• Characterisation of a novel model of Parkinson's disease by intra-striatal infusion of the pesticide rotenone.

  2011cites this paper
• Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain.

  2010cites this paper
• Deep Brain Stimulation of the Center Median–Parafascicular Complex of the Thalamus Has Efficient Anti-Parkinsonian Action Associated with Widespread Cellular Responses in the Basal Ganglia Network in a Rat Model of Parkinson's Disease

  2010cites this paper
• Characterisation of behavioural and neurodegenerative changes induced by intranigral 6‐hydroxydopamine lesions in a mouse model of Parkinson’s disease

  2010influential citation
• Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat.

  2010cites this paper
• Graft-mediated functional recovery on a skilled forelimb use paradigm in a rodent model of Parkinson's disease is dependent on reward contingency.

  2010cites this paper
• Differential fate and functional outcome of lithium chloride primed adult neural progenitor cell transplants in a rat model of Huntington disease

  2010cites this paper
• Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson's disease.

  2009cites this paper
• AAV-mediated expression of Bcl-xL or XIAP fails to induce neuronal resistance against quinolinic acid-induced striatal lesioning.

  2008cites this paper
• Animal models of Parkinson’s disease and L-dopa induced dyskinesia: How close are we to the clinic?

  2008cites this paper
• AAV–BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment

  2008cites this paper
• Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat.

  2008cites this paper
• Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease.

  2008cites this paper
• AAV-vector mediated gene delivery for Huntington's Disease : an investigative therapeutic study.

  2007cites this paper
• Neural transplantation in Parkinson's Disease

  2007cites this paper
• The corridor task: striatal lesion effects and graft-mediated recovery in a model of Huntington's disease.

  2007cites this paper
• Further validation of the corridor task for assessing deficit and recovery in the hemi-Parkinsonian rat: restoration of bilateral food retrieval by dopamine receptor agonism.

  2006cites this paper
• Lentivector‐mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model

  2005cites this paper
• Brain repair: Moving along

  2005cites this paper